Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.
about
Androgen depletion up-regulates cadherin-11 expression in prostate cancer.Current role of diethylstilbestrol in the management of advanced prostate cancer.Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo.
P2860
Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.
@ast
Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.
@en
type
label
Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.
@ast
Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.
@en
prefLabel
Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.
@ast
Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.
@en
P2860
P356
P1476
Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.
@en
P2093
Eli Rosenbaum
Michael A Carducci
P2860
P304
P356
10.1517/14656566.4.6.875
P407
P577
2003-06-01T00:00:00Z